-
ARTV Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Artiva Biotherapeutics, Inc. Common Stock (ARTV)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 56.14 mm | 56.14 mm | 56.14 mm | |||
Cash burn (monthly) | (no burn) | 6.11 mm | (no burn) | |||
Cash used (since last report) | n/a | 17.15 mm | n/a | |||
Cash remaining | n/a | 38.99 mm | n/a | |||
Runway (months of cash) | n/a | 6.4 | n/a |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Oct 24 | Moore Alison | Director Stock Option Common Stock | Grant | Acquire A | No | No | 10.48 | 27,500 | 288.20 k | 27,500 |
12 Sep 24 | Neha Krishnamohan | Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 50,000 |
12 Sep 24 | Bush Jennifer | Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 72,799 |
12 Sep 24 | Heather Raymon | Common Stock | Grant | Acquire A | No | No | 0 | 10,000 | 0.00 | 10,000 |